Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 3395256)

Published in Arch Neurol on August 01, 1988

Authors

G E Gibson1, K F Sheu, J P Blass, A Baker, K C Carlson, B Harding, P Perrino

Author Affiliations

1: Department of Neurology, Cornell University Medical College, White Plains, NY 10605.

Articles citing this

The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis (2010) 1.60

Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci (2005) 1.55

The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta (2013) 1.34

Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta (2009) 1.33

Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord (2007) 1.29

S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis (2010) 1.26

Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiol Aging (2008) 1.24

Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid Redox Signal (2011) 1.21

Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis (2011) 1.18

Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10

A construct with fluorescent indicators for conditional expression of miRNA. BMC Biotechnol (2008) 1.08

Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol Aspects Med (2011) 1.05

Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid Med Cell Longev (2013) 0.99

Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol Dis (2007) 0.99

Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neuroscience (2008) 0.99

Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am J Pathol (1996) 0.99

Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry (2005) 0.98

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis (2010) 0.95

Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis. EBioMedicine (2015) 0.94

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol (2010) 0.94

Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis. J Neurochem (2009) 0.94

Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv Pharmacol (2012) 0.93

Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol Dis (2012) 0.93

A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. J Alzheimers Dis (2010) 0.93

Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes. Mol Cell Neurosci (2012) 0.92

Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta (2007) 0.92

Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med (2009) 0.92

Vitamin B1 (thiamine) and dementia. Ann N Y Acad Sci (2016) 0.89

Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease. Ann N Y Acad Sci (2008) 0.89

Brain [U-13 C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity. J Neurosci Res (2011) 0.89

Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins. Neurobiol Dis (2009) 0.88

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease. Mol Neurodegener (2011) 0.88

Inactivation and reactivation of the mitochondrial α-ketoglutarate dehydrogenase complex. J Biol Chem (2011) 0.87

OGDHL is a modifier of AKT-dependent signaling and NF-κB function. PLoS One (2012) 0.87

Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol (1998) 0.87

Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a. J Neurochem (2011) 0.87

A non-specific effect associated with conditional transgene expression based on Cre-loxP strategy in mice. PLoS One (2011) 0.86

Kinetic Modeling of the Mitochondrial Energy Metabolism of Neuronal Cells: The Impact of Reduced α-Ketoglutarate Dehydrogenase Activities on ATP Production and Generation of Reactive Oxygen Species. Int J Cell Biol (2012) 0.85

Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation. Neurobiol Aging (2011) 0.85

Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Clin Exp Metastasis (2015) 0.83

Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. J Proteomics (2011) 0.83

Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental? J Neurochem (2016) 0.82

Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2007) 0.81

NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease. Acta Neuropathol (1992) 0.81

Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment. Curr Pharm Des (2011) 0.80

Thiamine and oxidants interact to modify cellular calcium stores. Neurochem Res (2010) 0.80

An update on the role of mitochondrial α-ketoglutarate dehydrogenase in oxidative stress. Mol Cell Neurosci (2012) 0.80

Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. Biochem Pharmacol (2013) 0.77

Behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases. Int J Alzheimers Dis (2010) 0.77

Role of dietary protein and thiamine intakes on cognitive function in healthy older people: a systematic review. Nutrients (2015) 0.77

Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions? Age (Omaha) (1998) 0.77

Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: evidence for neuron-glia communication during energetic crisis. Mol Cell Neurosci (2015) 0.77

Serotonin as a putative scavenger of hypohalous acid in the brain. Biochim Biophys Acta (2015) 0.76

Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. J Alzheimers Dis (2015) 0.76

Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease. Neurochem Int (2016) 0.76

Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy. Mol Neurobiol (2016) 0.75

Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Neurotherapeutics (2015) 0.75

Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons. Toxicol Sci (2016) 0.75

Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease. J Cereb Blood Flow Metab (2015) 0.75

Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease. PLoS One (2017) 0.75

Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer's-Disease Related Pathology. Mol Neurobiol (2016) 0.75

Articles by these authors

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med (1991) 13.91

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85

Landscape ecology of algal symbionts creates variation in episodes of coral bleaching. Nature (1997) 4.53

Sequence and expression of human estrogen receptor complementary DNA. Science (1986) 4.36

A common molecular basis for three inherited kidney stone diseases. Nature (1996) 4.26

The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. Immunology (1970) 3.70

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg (1982) 3.65

A clinicopathological study of autism. Brain (1998) 3.49

A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain (2000) 2.96

The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature (2000) 2.88

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr (1996) 2.77

GATA3 haplo-insufficiency causes human HDR syndrome. Nature (2000) 2.73

Grieving abortion loss. AWHONN Lifelines (2002) 2.66

Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med (1977) 2.47

A 42K outer-membrane protein is a component of the yeast mitochondrial protein import site. Nature (1989) 2.18

Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13

Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology (2008) 2.10

Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08

Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02

A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. Br J Psychiatry (1993) 1.98

The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology (1970) 1.96

Outcome of anorexia nervosa. Lancet (1979) 1.94

Instruments for the functional assessment of older patients. N Engl J Med (1990) 1.93

Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol (1992) 1.85

The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc (1999) 1.71

Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry (2000) 1.64

Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62

Fluorescence as a potential monitoring tool for recycled water systems: a review. Water Res (2008) 1.62

Middle ear transmission disorders--tympanic membrane vibration analysis by laser-Doppler-vibrometry. Acta Otolaryngol (1994) 1.60

Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc (1998) 1.60

Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59

New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med (1999) 1.58

Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56

Is a large-scale DNA-based inventory of ancient life possible? J Hered (2005) 1.56

Prospective audit of multiple penetrating injuries to the colon: further support for primary closure. J R Coll Surg Edinb (1996) 1.55

Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J Clin Invest (1981) 1.54

Stress induces peroxisome biogenesis genes. EMBO J (2000) 1.51

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (2008) 1.49

A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transpl (2001) 1.47

Germline and mosaic mutations of FLN1 in men with periventricular heterotopia. Neurology (2004) 1.47

Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm (Vienna) (1998) 1.44

Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44

Validation of recombinant Sendai virus in a non-natural host model. Gene Ther (2010) 1.42

Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence. Brain (2003) 1.40

Identifying high yield sources of patients with coronary artery disease for clinical trials: lessons from the Asymptomatic Cardiac Ischemia Pilot (ACIP) experience. The ACIP Study Group. Clin Cardiol (1998) 1.39

Managing aspiration. Br Dent J (2012) 1.38

The mitochondrial targeting function of randomly generated peptide sequences correlates with predicted helical amphiphilicity. J Biol Chem (1989) 1.38

Survival in Alzheimer's disease and vascular dementias. Neurology (1985) 1.37

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther (2002) 1.36

Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol (2000) 1.35

Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett (1997) 1.33

Sequences from a prokaryotic genome or the mouse dihydrofolate reductase gene can restore the import of a truncated precursor protein into yeast mitochondria. Proc Natl Acad Sci U S A (1987) 1.32

A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry (1999) 1.32

Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30

The complete DNA sequence and genomic organization of the avian adenovirus CELO. J Virol (1996) 1.30

Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther (1994) 1.29

An NADH-linked spectrophotometric assay for pyruvate dehydrogenase complex in crude tissue homogenates. J Biol Chem (1981) 1.22

ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res (1989) 1.21

A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest (1970) 1.21

Two genes encode the adenine nucleotide translocator of maize mitochondria. Isolation, characterisation and expression of the structural genes. Eur J Biochem (1989) 1.21

Precise dating of Dansgaard-Oeschger climate oscillations in western Europe from stalagmite data. Nature (2003) 1.20

The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int (2000) 1.20

Anorexia nervosa. Psychoneurotic characteristics of parents: relationship to prognosis. A quantitative study. J Psychosom Res (1974) 1.18

UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab (2003) 1.18

Typical absence seizures in adults: clinical, EEG, video-EEG findings and diagnostic/syndromic considerations. J Neurol Neurosurg Psychiatry (1992) 1.18

Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol (1983) 1.17

Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics (1999) 1.17

Zn2+ inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. J Biol Chem (2000) 1.16

The carboxyl terminus of isocitrate lyase is not essential for import into glyoxysomes in an in vitro system. J Biol Chem (1993) 1.16

Evaluation of treatment for autistic children and their parents. J Am Acad Child Psychiatry (1982) 1.16

The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology (1972) 1.15

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol (1983) 1.15

Pharmacological uses and perspectives of heavy water and deuterated compounds. Can J Physiol Pharmacol (1999) 1.15

Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer (1983) 1.14

Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology (1984) 1.14

Factors associated with duration of survival in Alzheimer's disease. Biol Psychiatry (1985) 1.13

Low activities of the pyruvate and oxoglutarate dehydrogenase complexes in five patients with Friedreich's ataxia. N Engl J Med (1976) 1.13

Catalytic nucleic acids: from lab to applications. Pharmacol Rev (2000) 1.12

Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) (2006) 1.11

Isolation and sequence analysis of a cDNA encoding the ATP/ADP translocator of Zea mays L. Nucleic Acids Res (1985) 1.10

Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg (1997) 1.10

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther (2011) 1.10

Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J (1975) 1.09

Clinical features of anorexia nervosa. A study of a consecutive series of 102 female patients. J Psychosom Res (1980) 1.07

Deaths from antidepressants in England and Wales 1993-1997: analysis of a new national database. Psychol Med (2001) 1.07

Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci U S A (1997) 1.07

Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection. Addiction (1996) 1.07

Mites infesting phlebotomine sandflies in southern Sinai, Egypt. Med Vet Entomol (1996) 1.07

Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem (1976) 1.06

Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J Neurochem (1999) 1.05

Assessing phytoremediation's progress in the United States and Europe. Environ Sci Technol (2001) 1.05

Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp Neurol (2000) 1.04

N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J Neurochem (2001) 1.04

Whipple's disease confined to the CNS presenting with multiple intracerebral mass lesions. J Neurol Neurosurg Psychiatry (1991) 1.04